Bridgeway Capital Management, LLC Sesen Bio, Inc. Transaction History

Bridgeway Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $182,500 - $320,000	250,000 New	250,000 $204,000
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $547,855 - $3.49 Million	-711,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $276,860 - $591,820	-127,000 Reduced 15.15%	711,500 $3.29 Million
Q3 2020 Nov 16, 2020	SELL	$0.67 - $1.4 $56,950 - $118,999	-85,000 Reduced 9.2%	838,500 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$0.52 - $0.87 $263,380 - $440,655	506,500 Added 121.46%	923,500 $665,000
Q4 2019 Feb 14, 2020	BUY	$0.89 - $1.5 $178,000 - $300,000	200,000 Added 92.17%	417,000 $434,000
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.51 $17,680 - $25,670	17,000 Added 8.5%	217,000 $254,000
Q1 2019 May 15, 2019	BUY	$0.69 - $1.47 $69,000 - $147,000	100,000 Added 100.0%	200,000 $206,000
Q3 2018 Nov 13, 2018	BUY	$1.54 - $2.38 $154,000 - $238,000	100,000 New	100,000 $215,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.